Takip et
Eman M El-Khateeb
Eman M El-Khateeb
Clinical Pharmacy Lecturer, Tanta university, Egypt
pharm.tanta.edu.eg üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Physiological‐based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20‐years; in‐depth analysis of applications, organizations, and platforms
E El‐Khateeb, S Burkhill, S Murby, H Amirat, A Rostami‐Hodjegan, ...
Biopharmaceutics & Drug Disposition 42 (4), 107-117, 2021
1072021
Non-uniformity of changes in drug-metabolizing enzymes and transporters in liver cirrhosis: implications for drug dosage adjustment
E El-Khateeb, B Achour, ZM Al-Majdoub, J Barber, A Rostami-Hodjegan
Molecular Pharmaceutics 18 (9), 3563-3577, 2021
552021
time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment
E El‐Khateeb, AS Darwich, B Achour, V Athwal, A Rostami‐Hodjegan
Alimentary Pharmacology & Therapeutics 54 (4), 388-401, 2021
452021
Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats
A El-Sisi, S Hegazy, E El-Khateeb
PPAR research 2013 (1), 781348, 2013
362013
Pharmacokinetics under the COVID‐19 storm
V Pilla Reddy, E El‐Khateeb, H Jo, N Giovino, E Lythgoe, S Sharma, ...
British Journal of Clinical Pharmacology 89 (1), 158-186, 2020
322020
Mass Spectrometry‐Based Abundance Atlas of ABC Transporters in Human Liver, Gut, Kidney, Brain, and Skin
JB Zubida M. Al‐Majdoub, Brahim Achour, Narciso Couto, Martyn Howard ...
FEBS letters, 2020
292020
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: applications in translational pharmacology and recommendations for best practice
E El-Khateeb, AM Vasilogianni, S Alrubia, ZM Al-Majdoub, N Couto, ...
Pharmacology & Therapeutics 203, 107397, 2019
252019
Proteomic quantification of changes in abundance of drug-metabolizing enzymes and drug transporters in human liver cirrhosis: different methods, similar outcomes
E El-Khateeb, ZM Al-Majdoub, A Rostami-Hodjegan, J Barber, B Achour
Drug Metabolism and Disposition 49 (8), 610-618, 2021
232021
Scaling factors for clearance in adult liver cirrhosis
E El-Khateeb, B Achour, D Scotcher, ZM Al-Majdoub, V Athwal, J Barber, ...
Drug Metabolism and Disposition 48 (12), 1271-1282, 2020
232020
Bioanalytical strategies in drug discovery and development
A Thakur, Z Tan, T Kameyama, E El-Khateeb, S Nagpal, S Malone, ...
Drug Metabolism Reviews 53 (3), 434-458, 2021
122021
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease
AM Vasilogianni, E El-Khateeb, ZM Al-Majdoub, S Alrubia, ...
Journal of Proteomics 263, 104601, 2022
112022
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins
AM Vasilogianni, E El-Khateeb, B Achour, S Alrubia, A Rostami-Hodjegan, ...
Journal of Proteomics 261, 104572, 2022
82022
A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new …
SJ Alarfaj, MM Bahaa, HA Yassin, E El-Khateeb, FA Kotkata, ...
European Review for Medical & Pharmacological Sciences 27 (16), 2023
72023
The potential therapeutic effect of metformin in type 2 diabetic patients with severe COVID-19.
HM Al-Kuraishy, AI Al-Gareeb, AA El Kholy, E El-Khateeb, A Alexiou, ...
European Review for Medical & Pharmacological Sciences 27 (23), 2023
62023
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind …
E El-Khateeb, EI El-Berri, EM Mosalam, MZ Nooh, S Abdelsattar, ...
Frontiers in Pharmacology 14, 1153653, 2023
42023
A Randomized Controlled Trial Comparing Tacrolimus versus Hydrocortisone for the Treatment of Atopic Dermatitis in Children: New Perspectives on Interferon Gamma-Induced …
M Bahaa, AY Binsaleh, TA Elmasry, EI Elberri, FA Kotkata, E El-Khateeb, ...
Frontiers in Medicine 11, 1399305, 2024
22024
Using Prior Knowledge on Systems Through PBPK to Gain Further Insight into Routine Clinical Data on Trough Concentrations: The Case of Tacrolimus in Chronic Kidney Disease
E El-Khateeb, R Chinnadurai, J Al Qassabi, D Scotcher, AS Darwich, ...
Therapeutic Drug Monitoring, 10.1097, 2022
12022
Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study
SJ Alarfaj, MM Bahaa, TA Elmasry, EI Elberri, E El-Khateeb, AO Hamouda, ...
Drug Design, Development and Therapy, 5239-5253, 2024
2024
Exploring the Feasibility of a Bracketing Approach Utilizing Modeling for Development of Long-Acting Injectables for Regulatory Approval—A Case Study Using Levonorgestrel
S Cole, H Pertinez, AS Butler, E Kerwash, S Bhat, E El-Khateeb, A Owen
Pharmaceuticals 17 (12), 1640, 2024
2024
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator
L Curry, S Alrubia, FY Bois, R Clayton, E El-Khateeb, TN Johnson, ...
CPT Pharmacometrics Syst Pharmacol, 1-19, 2024
2024
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20